BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pahle J, Walther W. Vectors and strategies for nonviral cancer gene therapy. Expert Opin Biol Ther 2016;16:443-61. [PMID: 26761200 DOI: 10.1517/14712598.2016.1134480] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Muripiti V, Mujahid TY, Boddeda VHV, Tiwari S, Marepally SK, Patri SV, Gopal V. Structure-activity relationship of serotonin derived tocopherol lipids. Int J Pharm 2019;554:134-48. [PMID: 30389474 DOI: 10.1016/j.ijpharm.2018.10.072] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Song L, Ding A, Zhang K, Gong B, Lu Z, He L. Degradable polyesters via ring-opening polymerization of functional valerolactones for efficient gene delivery. Org Biomol Chem 2017;15:6567-74. [DOI: 10.1039/c7ob00822h] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
3 Egorova A, Selutin A, Maretina M, Selkov S, Baranov V, Kiselev A. Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells. Pharmaceuticals (Basel) 2020;13:E300. [PMID: 33050526 DOI: 10.3390/ph13100300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Puchkov PA, Maslov MA. Lipophilic Polyamines as Promising Components of Liposomal Gene Delivery Systems. Pharmaceutics 2021;13:920. [PMID: 34205825 DOI: 10.3390/pharmaceutics13060920] [Reference Citation Analysis]
5 Bottai G, Truffi M, Corsi F, Santarpia L. Progress in nonviral gene therapy for breast cancer and what comes next? Expert Opinion on Biological Therapy 2017;17:595-611. [DOI: 10.1080/14712598.2017.1305351] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
6 Pylaev T, Vanzha E, Avdeeva E, Khlebtsov B, Khlebtsov N. A novel cell transfection platform based on laser optoporation mediated by Au nanostar layers. J Biophotonics 2019;12:e201800166. [PMID: 30203552 DOI: 10.1002/jbio.201800166] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
7 Qi Y, Xu C, Xu F. Degradable branched polycationic systems for nucleic acid delivery. WIREs Nanomed Nanobiotechnol 2020;12. [DOI: 10.1002/wnan.1631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Poorebrahim M, Sadeghi S, Fakhr E, Abazari MF, Poortahmasebi V, Kheirollahi A, Askari H, Rajabzadeh A, Rastegarpanah M, Linē A, Cid-Arregui A. Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects. Crit Rev Clin Lab Sci 2019;56:393-419. [PMID: 31314617 DOI: 10.1080/10408363.2019.1633512] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
9 Sultana N, Magadum A, Hadas Y, Kondrat J, Singh N, Youssef E, Calderon D, Chepurko E, Dubois N, Hajjar RJ, Zangi L. Optimizing Cardiac Delivery of Modified mRNA. Mol Ther 2017;25:1306-15. [PMID: 28389322 DOI: 10.1016/j.ymthe.2017.03.016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
10 Haque ST, Karim ME, Abidin SAZ, Othman I, Holl MMB, Chowdhury EH. Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells. Nanomaterials (Basel) 2020;10:E834. [PMID: 32349272 DOI: 10.3390/nano10050834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Liu H, Wang G, Yang Y, Yu L, Wang L, Wen Z, Hu X, Zou H, Qiu X. Delivery Efficiency of miR-21i-CPP-SWCNT and Its Inhibitory Effect on Fibrosis of the Renal Mesangial Cells. Journal of Nanomaterials 2016;2016:1-8. [DOI: 10.1155/2016/3451685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Botto C, Mauro N, Amore E, Martorana E, Giammona G, Bondì ML. Surfactant effect on the physicochemical characteristics of cationic solid lipid nanoparticles. International Journal of Pharmaceutics 2017;516:334-41. [DOI: 10.1016/j.ijpharm.2016.11.052] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
13 Gutiérrez-Lovera C, Vázquez-Ríos AJ, Guerra-Varela J, Sánchez L, de la Fuente M. The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines. Genes (Basel) 2017;8:E349. [PMID: 29182542 DOI: 10.3390/genes8120349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
14 Wang J, Zhang L, Wang X, Fu S, Yan G. Acid-labile poly(amino alcohol ortho ester) based on low molecular weight polyethyleneimine for gene delivery. J Biomater Appl 2017;32:349-61. [PMID: 28670944 DOI: 10.1177/0885328217717374] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Vago R, Collico V, Zuppone S, Prosperi D, Colombo M. Nanoparticle-mediated delivery of suicide genes in cancer therapy. Pharmacol Res 2016;111:619-41. [PMID: 27436147 DOI: 10.1016/j.phrs.2016.07.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
16 Naddafi F, Mahboudi F, Tabarzad M, Aliabadi Farahani Z, Hosein Shirazi F, Davami F. The Epigenetic Regulation of Blinatumomab Gene Expression: Tumor Cell-dependent T cell Response against Lymphoma Cells and Cytotoxic Activity. Int J Mol Cell Med 2019;8:55-66. [PMID: 32195205 DOI: 10.22088/IJMCM.BUMS.8.1.55] [Reference Citation Analysis]
17 Navarro SA, Carrillo E, Griñán-Lisón C, Martín A, Perán M, Marchal JA, Boulaiz H. Cancer suicide gene therapy: a patent review. Expert Opin Ther Pat 2016;26:1095-104. [PMID: 27424657 DOI: 10.1080/13543776.2016.1211640] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
18 Sheikh-Hosseini M, Larijani B, Gholipoor Kakroodi Z, Shokoohi M, Moarefzadeh M, Sayahpour FA, Goodarzi P, Arjmand B. Gene Therapy as an Emerging Therapeutic Approach to Breast Cancer: New Developments and Challenges. Hum Gene Ther 2021. [PMID: 33307949 DOI: 10.1089/hum.2020.199] [Reference Citation Analysis]
19 Chen W, Yao S, Wan J, Tian Y, Huang L, Wang S, Akter F, Wu Y, Yao Y, Zhang X. BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. J Control Release 2021;333:129-38. [PMID: 33775685 DOI: 10.1016/j.jconrel.2021.03.029] [Reference Citation Analysis]
20 Zaitseva TS, Alcazar C, Zamani M, Hou L, Sawamura S, Yakubov E, Hopkins M, Woo YJ, Paukshto MV, Huang NF. Aligned Nanofibrillar Scaffolds for Controlled Delivery of Modified mRNA. Tissue Eng Part A 2019;25:121-30. [PMID: 29717619 DOI: 10.1089/ten.TEA.2017.0494] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Bellotti E, Cascone MG, Barbani N, Rossin D, Rastaldo R, Giachino C, Cristallini C. Targeting Cancer Cells Overexpressing Folate Receptors with New Terpolymer-Based Nanocapsules: Toward a Novel Targeted DNA Delivery System for Cancer Therapy. Biomedicines 2021;9:1275. [PMID: 34572461 DOI: 10.3390/biomedicines9091275] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Jiang P, Zhu Y, Kang K, Luo B, He J, Wu Y. Protein corona of magnetic PEI/siRNA complex under the influence of a magnetic field improves transfection efficiency via complement and coagulation cascades. J Mater Chem B 2019;7:4207-16. [DOI: 10.1039/c9tb00746f] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Yang B, Song BP, Shankar S, Guller A, Deng W. Recent advances in liposome formulations for breast cancer therapeutics. Cell Mol Life Sci 2021;78:5225-43. [PMID: 33974093 DOI: 10.1007/s00018-021-03850-6] [Reference Citation Analysis]
24 Zhao J, Han F, Zhao P, Wen X, Lin C. Dextranated poly(urethane amine)s designed for systemic gene delivery in ovarian cancer therapy. J Mater Chem B 2017;5:6119-27. [DOI: 10.1039/c7tb01641g] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Singh V, Khan N, Jayandharan GR. Vector engineering, strategies and targets in cancer gene therapy. Cancer Gene Ther 2021. [PMID: 33859378 DOI: 10.1038/s41417-021-00331-7] [Reference Citation Analysis]
26 McCrudden CM, McBride JW, McCaffrey J, McErlean EM, Dunne NJ, Kett VL, Coulter JA, Robson T, McCarthy HO. Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer. Cancer Nanotechnol 2018;9:5. [PMID: 29899810 DOI: 10.1186/s12645-018-0040-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
27 Nabzdyk CS, Pradhan-Nabzdyk L, LoGerfo FW. RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations. J Transl Med 2017;15:164. [PMID: 28754174 DOI: 10.1186/s12967-017-1270-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
28 Fernandez-Piñeiro I, Pensado A, Badiola I, Sanchez A. Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems. Eur J Pharm Biopharm 2018;125:85-94. [PMID: 29355685 DOI: 10.1016/j.ejpb.2018.01.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
29 Zhou Z, Liu X, Zhu D, Wang Y, Zhang Z, Zhou X, Qiu N, Chen X, Shen Y. Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration. Adv Drug Deliv Rev 2017;115:115-54. [PMID: 28778715 DOI: 10.1016/j.addr.2017.07.021] [Cited by in Crossref: 180] [Cited by in F6Publishing: 172] [Article Influence: 45.0] [Reference Citation Analysis]
30 Ma Y, Zhao W, Li Y, Pan Y, Wang S, Zhu Y, Kong L, Guan Z, Wang J, Zhang L, Yang Z. Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo. Biomaterials 2019;197:182-93. [PMID: 30660994 DOI: 10.1016/j.biomaterials.2018.12.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
31 Liu H, Liu C, Ye L, Ma D, He X, Tang Q, Zhao X, Zou H, Chen X, Liu P. Nanoassemblies with Effective Serum Tolerance Capability Achieving Robust Gene Silencing Efficacy for Breast Cancer Gene Therapy. Adv Mater 2021;33:e2003523. [PMID: 33354783 DOI: 10.1002/adma.202003523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Deepak P, Siddalingam R, Kumar P, Anand S, Thakur S, Jagdish B, Jaiswal S. Gene based nanocarrier delivery for the treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2020;59:101837. [DOI: 10.1016/j.jddst.2020.101837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ayatollahi S, Salmasi Z, Hashemi M, Askarian S, Oskuee RK, Abnous K, Ramezani M. Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells. Int J Biochem Cell Biol 2017;92:210-7. [PMID: 29031805 DOI: 10.1016/j.biocel.2017.10.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
34 Zhang Z, Qiu N, Wu S, Liu X, Zhou Z, Tang J, Liu Y, Zhou R, Shen Y. Dose-Independent Transfection of Hydrophobized Polyplexes. Adv Mater 2021;33:e2102219. [PMID: 33991017 DOI: 10.1002/adma.202102219] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Gourvest M, Brousset P, Bousquet M. Long Noncoding RNAs in Acute Myeloid Leukemia: Functional Characterization and Clinical Relevance. Cancers (Basel) 2019;11:E1638. [PMID: 31653018 DOI: 10.3390/cancers11111638] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
36 Hou X, Shou C, He M, Xu J, Cheng Y, Yuan Z, Lan M, Zhao Y, Yang Y, Chen X, Gao F. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy. Acta Pharm Sin B 2020;10:1741-53. [PMID: 33088693 DOI: 10.1016/j.apsb.2020.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
37 Malaekeh-Nikouei B, Rezaee M, Gholami L, Sanjar Mousavi N, Kazemi Oskuee R. Synthesis, characterization and evaluation of transfection efficiency of dexamethasone conjugated poly(propyleneimine) nanocarriers for gene delivery#. Pharm Biol 2018;56:519-27. [PMID: 30270694 DOI: 10.1080/13880209.2018.1517183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
38 Draberova L, Tumova M, Draber P. Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins. Front Immunol 2021;12:670205. [PMID: 34248949 DOI: 10.3389/fimmu.2021.670205] [Reference Citation Analysis]
39 Sun Y, Long J, Yin Y, Li H, Jiang E, Zeng C, Zhu W. Characterization of CSF2A fusion gene and its effect on Epstein-Barr virus-positive tumor cells. J Med Virol 2018;90:1750-6. [PMID: 29900557 DOI: 10.1002/jmv.25240] [Reference Citation Analysis]
40 Rubio MT, Galaine J, Borg C, Daguindau É. Biologie, concepts et principes des CAR-T cells. Bull Cancer 2018;105 Suppl 2:S135-46. [PMID: 30686352 DOI: 10.1016/S0007-4551(19)30044-X] [Reference Citation Analysis]
41 Zhu D, Shen H, Tan S, Hu Z, Wang L, Yu L, Tian X, Ding W, Ren C, Gao C, Cheng J, Deng M, Liu R, Hu J, Xi L, Wu P, Zhang Z, Ma D, Wang H. Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy. Mol Ther 2018;26:2443-55. [PMID: 30241742 DOI: 10.1016/j.ymthe.2018.07.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
42 Vila-Gómez P, Noble JE, Ryadnov MG. Peptide Nanoparticles for Gene Packaging and Intracellular Delivery. Methods Mol Biol 2021;2208:33-48. [PMID: 32856254 DOI: 10.1007/978-1-0716-0928-6_3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Hu C, Jiang D, Wu M, Wang J, Zhang R. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer. J Cancer Res Clin Oncol 2020;146:1415-26. [DOI: 10.1007/s00432-020-03160-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
44 Karim ME, Tha KK, Othman I, Borhan Uddin M, Chowdhury EH. Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers. Pharmaceutics 2018;10:E65. [PMID: 29861465 DOI: 10.3390/pharmaceutics10020065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
45 Khalil IA, Sato Y, Harashima H. Recent advances in the targeting of systemically administered non-viral gene delivery systems. Expert Opin Drug Deliv 2019;16:1037-50. [PMID: 31432700 DOI: 10.1080/17425247.2019.1656196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Zhang C, Liu J, Zhong JF, Zhang X. Engineering CAR-T cells. Biomark Res 2017;5:22. [PMID: 28652918 DOI: 10.1186/s40364-017-0102-y] [Cited by in Crossref: 153] [Cited by in F6Publishing: 131] [Article Influence: 38.3] [Reference Citation Analysis]
47 Lin C, Jan M, Kuo JS. The microRNA expression profiles in extracellular vesicles from HeLa cancer cells in response to cationic lipid- or polyethylenimine-mediated gene delivery. Journal of Drug Targeting 2019;27:94-102. [DOI: 10.1080/1061186x.2018.1491977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
48 Roma-Rodrigues C, Rivas-García L, Baptista PV, Fernandes AR. Gene Therapy in Cancer Treatment: Why Go Nano? Pharmaceutics 2020;12:E233. [PMID: 32151052 DOI: 10.3390/pharmaceutics12030233] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 29.0] [Reference Citation Analysis]
49 Poorebrahim M, Abazari MF, Sadeghi S, Mahmoudi R, Kheirollahi A, Askari H, Wickström SL, Poortahmasebi V, Lundqvist A, Kiessling R, Cid-Arregui A. Genetically modified immune cells targeting tumor antigens. Pharmacol Ther 2020;214:107603. [PMID: 32553789 DOI: 10.1016/j.pharmthera.2020.107603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Lou B, Jin R, Cheng J, Wen X, Zhao P, Lin C. A hierarchical assembly strategy to engineer dextran-enveloped polyurethane nanopolyplexes for robust ovarian cancer gene therapy. Acta Biomater 2018;78:260-73. [PMID: 30071349 DOI: 10.1016/j.actbio.2018.07.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]